Fairvalue-Calculator Fairvalue-Calculator
EN DE

Equillium, Inc (EQ) Fair Value & Analysis

Healthcare · US · Market cap $193M

Price$2.84
Fair Value$2.04
Upside-28.2%
Quality95/100
Evidence: Low Range $1.53 – $2.54

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Equillium, Inc (EQ) currently trades at $2.84, while our model-based Fair Value estimate is $2.04 — implying the stock looks roughly 28.2% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States. The company develops EQ504, a novel AhR modulator that is in preclinical-stage for the treatment of ulcerative colitis and lung inflammation diseases. It also develops EQ302, a bi-specific inhibitor of IL-15 and IL-21 formulated for oral delivery for the treatment of celiac diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -32% Regeneron Pharmaceuticals, Inc (REGN) -4% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +1% Alnylam Pharmaceuticals, Inc (ALNY) -82%

Frequently asked questions

Is Equillium, Inc (EQ) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $2.04 versus a price of $2.84 — about −28% (overvalued). Model-based estimate, not financial advice.
What is the fair value of EQ?
Our 21-model fair value for Equillium, Inc is $2.04 (as of Jun 24, 2026), built from audited fundamentals. The current price is $2.84.
What is the quality score of EQ?
Equillium, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.